Answers are grounded in this paper and cite their sources.
This review determines the association between ovarian reserve markers, anti-Müllerian hormone (AMH) and antral follicle count (AFC), with risk of miscarriage in women undergoing assisted reproductive technology. A systematic search of PubMed, Embase, Cochrane Library and Google Scholar from inception to September 2023 identified 16 retrospective studies, including 43,147 patients. A meta-analysis using a random effects model demonstrated that low AMH concentration is associated with a significantly increased risk of miscarriage compared with medium and high AMH concentration (OR 1.48, 95% CI 1.20 to 1.83, P = 0.0002). When stratified by age, the risk remained significant in women aged younger than 35 years (OR 1.34, 95% CI 1.17 to 1.54, P < 0.0001); however, results were not significant among women aged 35 years or younger (OR 1.29, 95% CI 0.95 to 1.76, P = 0.10). Similarly, low AFC was associated with an increased risk of miscarriage across all ages (OR 1.80, 95% CI 1.33 to 2.45, P = 0.0002). After age adjustment, the association was significant in women aged younger than 35 years (OR 1.61, 95% CI 1.20 to 2.16, P = 0.002), but not among women aged 35 years or older (OR 1.41, 95% CI 0.90 to 2.22, P = 0.14). Therefore, a reduced ovarian reserve is associated with an increased risk of miscarriage, although results are only significant among women aged younger than 35 years.
No takes yet. Share an insight, caveat, or question.
Kasaven et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: